Rabeprazole in Treatment of Acid Peptic Diseases (Results of Three Placebo-Controlled Dose-Response Clinical Trials in Duodenal Ulcer, Gastric Ulcer, and Gastroesophageal Reflux Disease (GERD)) (original) (raw)
References
Physicians Desk Reference, Medical Economics Company, Inc., Montvale, New Jersey, 1996
Havu N: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35(suppl 1):42-55, 1986 Google Scholar
McTavish D, Buckley MM, Heel RC: Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 42:138-170, 1991 Google Scholar
Morii M, Takata H, Fujisaki H, Takeguchi N: The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+,K+-ATP~S~ is correlated with the rate of acid-activation of the inhibitor. Biochem Pharmacol 39:661-667, 1990 Google Scholar
Fujisaki H, Shibata H, Oketani K, Murakami M, Fujimoto M, Wakabayashi T, Yamatsu I, Takeguchi N: Effects of the proton pump inhibitor, E3810, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Drug Invest 3:328-332, 1991 Google Scholar
Hirai M, Azuma T, Ito S, Kato T, Kohli Y: A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori. J Gastroenterol 30:461-464, 1995 Google Scholar
Tsuchiya M, Imamura L, Park JB, Kobashi K: Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor. Biol Pharm Bull 18:1053-1056, 1995 Google Scholar
Eisai, Inc: Data on file. Eisai, Teaneck, New Jersey.
Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95:903-912, 1988 Google Scholar
Klein PD, Graham DY: Minimum analysis requirements for the detection of Helicobacter pylori infection by the 13c-urea breath test. Am J Gastroenterol 88: 1865-1869, 1993 Google Scholar
Asaka M, Kato M, Kudo M, Meguro T, Kimura T, Miyazaki T, Inoue K: The role of Helicobacter pylori in peptic ulcer disease. Gastroenterol Jpn 28(suppl 5): 163-167, 1993 Google Scholar
Bardhan KD, Dekkers CP, Lam SK, Nowak A, Schaffalitzky de Muckadell OB, Schutze **K,**Tildesley G, Kler L, Forster JK, Lacey LF, et al: GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther 9:497-506, 1995 Google Scholar
Beglinger C: Current perspectives in ulcer disease. Ther Umsch 47:681-685, 1990 Google Scholar
Bell GD, Powell KU: Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol Suppl 196:7-11, 1993 Google Scholar
Berstad K, Berstad A: Helicobacter pylori infection in peptic ulcer disease. Scand J Gastroenterol 28:561-567, 1993 Google Scholar
Fedotin MS: Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach. Postgrad Med 94:38-40, 43-45, 1993 Google Scholar
Gad A, Hradsky M, Furugard K, Malmodin B: Campylobacter pylori and gastroduodenal ulcer disease. A prospective study in a Swedish population. Scand J Gastroenterol Suppl 167:8185, 1989 Google Scholar
O'Connor HJ: The role of Helicobacter pylori in peptic ulcer disease. Scand J Gastroenterol Suppl 201:ll-15, 1994 Google Scholar
Rune S: Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion. Digestion 51 (suppl 1):ll-16, 1992 Google Scholar
Vaira D, Miglioli M, Mule P, Holton J, Menegatti M, Vergura M, Biasco G, Conte R, Logan RP, Barbara L: Prevalence of peptic ulcer in Helicobacter pylori-positive blood donors. Gut 35:309-312, 1994 Google Scholar
Good DJ, Dill S, Mossi S, Frey R, Beglinger C, Stalder GA, Meyer Wyss B: Sensitivitat und Spezifitat eines vereinfachten, standardisierten 13c-urea-~temtests zum Nachweis von Helicobacter pylori. Schweiz Med Wochenschr 121:764-766, 1991 Google Scholar
Klein PD, Graham DY: Minimum analysis requirements for the detection of Helicobacter pylori infection by the 13C-urea breath test. Am J Gastroenterol 88: 1865-1869, 1993 Google Scholar
Savarino V, Mela GS, Zentlin P, Cutela P, Mele M, Vigneri S, Celle G: Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. Dig Dis Sci 39:161-168, 1994 Google Scholar
Leiete LP, Johnson BT, Just RJ, Castell DO: Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91:1527-1531, 1996 Google Scholar
Cloud ML, Olovich K, Enas N, Bassion S, Humphries T: LY307640 versus placebo in healing erosive, ulcerative reflux esophagitis. Gastroenterology 108:A73, 1995 Google Scholar
Humphries TJ, Cloud ML, Enas N, Bassion S, McNamara M, Mele M, Vigneri S, Celle G, The U.S. Raberprazole Gastric Ulcer Study Group: Rabeprazole (E3810, LY307640) achieves high rates of healing in active gastric ulcer. Gastroenterology 110:A138, 1996 Google Scholar
Cloud ML, Olovich K, Enas N, Bassion S, Humphries T: LY307640 versus placebo in healing duodenal ulcers. Gastroenterology 108:A73, 1995 Google Scholar